Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

61.48
-1.9200-3.03%
Post-market: 61.480.00000.00%19:30 EDT
Volume:91.77K
Turnover:5.68M
Market Cap:176.69M
PE:-1.60
High:64.50
Open:64.50
Low:60.46
Close:63.40
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.00
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:2.11
PE(LYR):-1.21

Loading ...

Spruce Biosciences, Inc expected to post a loss of $8.82 a share - Earnings Preview

Reuters
·
May 08

BRIEF-Spruce Biosciences Further Strengthens Its Commercial Leadership Team With The Appointments Of Brian Walls As Vice President, Market Access And Darren Johnson As Vice President, Commercial Operations

Reuters
·
May 04

Spruce Biosciences Further Strengthens Its Commercial Leadership Team With the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations

THOMSON REUTERS
·
May 04

Spruce Biosciences, Inc expected to post a loss of $8.82 a share - Earnings Preview

Reuters
·
May 01

Spruce Biosciences Initiated at Buy by Craig-Hallum

Dow Jones
·
Apr 28

Craig-Hallum bullish on Spruce Biosciences, initiates with a Buy

TIPRANKS
·
Apr 27

Top Midday Decliners

MT Newswires Live
·
Apr 22

BUZZ-U.S. STOCKS ON THE MOVE-Intel, Teradyne, MSCI

Reuters
·
Apr 21

Top Premarket Decliners

MT Newswires Live
·
Apr 21

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Tractor Supply, RTX

Reuters
·
Apr 21

Spruce Biosciences Shares Down 15.9% Premarket After Co Announces Pricing of Equity Offering

THOMSON REUTERS
·
Apr 21

Spruce Biosciences, Inc - Prices Public Offering of 1,150,000 Shares at $50.00 per Share

THOMSON REUTERS
·
Apr 21

Spruce Biosciences down 13% at $60.50 after equity offering announcement

TIPRANKS
·
Apr 21

BUZZ-Spruce Biosciences falls after equity offering launch

Reuters
·
Apr 21

Spruce Biosciences announces common stock offering, no amount given

TIPRANKS
·
Apr 21

Spruce Biosciences launches public offering of common stock, pre-funded warrants

Reuters
·
Apr 21

Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Apr 21

Spruce Biosciences announces annual shareholder meeting via webcast

Reuters
·
Apr 10

BRIEF-Spruce Biosciences On March 16, Entered Termination Agreement With Kaken Pharmaceutical - SEC Filing

Reuters
·
Mar 21

Spruce Biosciences Ends Kaken Collaboration, Refocuses Pipeline

TIPRANKS
·
Mar 21